Hooper Holmes Announces $1.8 Million Investment

Biotech Investing

Hooper Holmes (NYSEMKT:HH) today announced a $1.8 million private placement equity offering to certain accredited investors.

Hooper Holmes (NYSEMKT:HH) today announced a $1.8 million private placement equity offering to certain accredited investors. Pursuant to securities purchase agreements entered into with the investors, the Company issued and sold approximately 1.3 million shares of common stock at $1.35 per share. In addition, the company issued warrants to purchase an equal number of shares with a strike price of $2.00 per share that will expire in four years. The securities purchase agreements are part of an exempt private equity offering in which the company may raise up to a total of $2.0 million on the sale of approximately 1.5 million shares and warrants.

Henry Dubois, President and CEO of Hooper Holmes commented, “This new capital will support our growth and provide additional liquidity during our historically strong third and fourth quarters. We continue to focus on executing our business plan and creating long-term value for our shareholders.”

About Hooper Holmes
Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs.

More information is available at hooperholmes.com and at accountablehealthsolutions.com.

This press release contains “forward-looking” statements, as such term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this press release reflect the Company’s current beliefs and expectations. Actual results or performance may differ materially from what is expressed in the forward looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expected. These risks and uncertainties include, but are not limited to, risks related to customer concerns about our financial health, our liquidity, uncertainty as to our working capital requirements over the next 12 to 24 months, our ability to maintain compliance with the financial covenants contained in our credit facility and term loan, declines in our business, our competition, and our ability to retain and grow our customer base and its related impact on revenue, our ability to recognize operational efficiencies and reduce costs, our ability to realize the expected benefits from the acquisition of Accountable Health Solutions, and such other factors as discussed in Part I, Item 1A, Risk Factors, and Part II, Item 7, Management’s Discussion and Analysis of Financial Conditions and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2015, and similar discussions in our other filings with the Securities and Exchange Commission (“SEC”). The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release to reflect the occurrence of unanticipated events, except as required by law.

For further information:
Hooper Holmes
Henry E. Dubois
President and CEO
(913) 764-1045
Investors: Andrew Berger
S.M. Berger & Company
(216) 464-6400
The Conversation (0)
×